ACRUX LIMITED - Announcements

0.00%

1.8¢

Market Cap $7.366M

Healthcare Drug Manufacturers - Specialty & Generic

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

ACR	Appendix 3B		21/12/10	166.87KB	Share
ACR	Change in substantial holding		17/12/10	79.92KB	Share
ACR	Appendix 3B		17/12/10	166.89KB	Share
ACR	Acrux receives US$87 million from Lilly		09/12/10	20.06KB	Share
ACR	Appendix 3Y		06/12/10	31.05KB	Share
ACR	Appendix 3B		06/12/10	166.89KB	Share
ACR	Appendix 3B		03/12/10	167.5KB	Share
ACR	2010 AGM Resolution Results		30/11/10	56.15KB	Share
ACR	2010 AGM Presentations	PRICE SENSITIVE	30/11/10	2.09MB	Share
ACR	Change in substantial holding		29/11/10	86.31KB	Share
ACR	Appendix 3B		25/11/10	166.93KB	Share
ACR	FDA Approval for AXIRON	PRICE SENSITIVE	24/11/10	82.21KB	Share
ACR	Market Update	PRICE SENSITIVE	24/11/10	49.12KB	Share
ACR	Trading Halt	PRICE SENSITIVE	24/11/10	41.63KB	Share
ACR	Change in substantial holding		04/11/10	86.78KB	Share
ACR	Response to ASX Price Query	PRICE SENSITIVE	01/11/10	95.12KB	Share
ACR	Change in substantial holding		29/10/10	92.01KB	Share
ACR	Appendix 4C - Quarterly Cash Flow Report	PRICE SENSITIVE	29/10/10	89.74KB	Share
ACR	2010 AGM Notice		22/10/10	242.48KB	Share
ACR	2010 Annual Report		21/10/10	1.02MB	Share
ACR	Acrux wins two 2010 Governor of Victoria Export Awards		05/10/10	18.68KB	Share
ACR	Appendix 3Y		31/08/10	31.18KB	Share
ACR	Appendix 3B		31/08/10	186.46KB	Share
ACR	Acrux Reports Maiden Profit of $46.6 Million		24/08/10	30.66KB	Share
ACR	Appendix 4E and 30 June 2010 Financial Report	PRICE SENSITIVE	24/08/10	241.25KB	Share
ACR	Update on Acrux female health products	PRICE SENSITIVE	10/08/10	26.48KB	Share
ACR	Appendix 4C - Quarterly Cash Flow Report	PRICE SENSITIVE	30/07/10	90.21KB	Share
ACR	Acrux CEO nominated in Entrepreneur Of The Year awards		17/06/10	83.08KB	Share
ACR	Investor Presentation 20 May 2010		20/05/10	2.24MB	Share
ACR	Settlement Agreement Transferring Luramist Assets to Acrux	PRICE SENSITIVE	11/05/10	20.59KB	Share
ACR	Appendix 4C - Quarterly Cash Flow Report	PRICE SENSITIVE	30/04/10	89.51KB	Share
ACR	New Drug Application for AXIRON accepted for review by FDA	PRICE SENSITIVE	15/04/10	19.95KB	Share
ACR	Appendix 3Y - Change of director's interest notice		06/04/10	10.69KB	Share
ACR	Acrux to regain rights to testosterone spray from Vivus	PRICE SENSITIVE	01/04/10	20.34KB	Share
ACR	Appendix 3B		19/03/10	166.87KB	Share
ACR	Appendix 3B		18/03/10	166.85KB	Share
ACR	AXIRON Licensing Presentation		17/03/10	374.33KB	Share
ACR	Acrux and Eli Lilly sign global licensing deal for AXIRON	PRICE SENSITIVE	16/03/10	31.23KB	Share
ACR	Market Update - A New Era For Acrux	PRICE SENSITIVE	16/03/10	62.02KB	Share
ACR	Trading Halt	PRICE SENSITIVE	15/03/10	41.78KB	Share
ACR	Appendix 3B		11/03/10	166.87KB	Share
TSN +ACR ADU AED AEJ AEZ AIO AJA RCM AMU ATM AVG AVX AXM AZZ ASQ BCS BLY BUL CAA CAH CBH CCP CDI PRG CIX CMV COK COZ CPL CRE CSV CTO CUV CVC CWT CXC CXM DCG DKN DLS DML DOM EAU EPX FEA FGE FML FPG FRS GDO ETM GPM GWR GXY GZL HDI NGI HGO HIG HIN HTA IDT ILF IMD IOH ITO IVA KAM KMD KRL KRM LLA MAE AEV MCE MCP MDT MEL MFG MIN 5GN GG8 MMW MRE MSF MTU MYR MYS NAN NBS NEC DTZ NGE NGF NKP NOD KZA NVT OAK OEL SYN AKE PBP ATH PME PPI PRU PTN AX1 RCI RCT VAU REF RFE RRL RXM SAR SFC SFH SFR SGN SGT SLR SNO SPL SRV SSM SUL TAM TCQ TGA TOX TPM TZL UBI UNS VIR VMG VPE VRL VTA WDS WEC WTP WYL ZSP	SandP Announces March SP/ASX Index Rebalance		05/03/10	35.82KB	Share
ACR	Appendix 3B		25/02/10	166.88KB	Share
ACR	Acrux Files Half Year Results		24/02/10	39.93KB	Share
ACR	Half Year Accounts and Appendix 4D	PRICE SENSITIVE	24/02/10	281.88KB	Share
ACR	Appendix 4C - Quarterly Cash Flow	PRICE SENSITIVE	29/01/10	89.3KB	Share
ACR	Acrux Submits New Drug Application for AXIRON to FDA	PRICE SENSITIVE	27/01/10	768.01KB	Share
ACR	Appendix 3B		07/12/09	166.91KB	Share
ACR	Appendix 3B		27/11/09	166.93KB	Share
ACR	2009 AGM Resolutions Results		24/11/09	54.33KB	Share
ACR	2009 AGM Chairmans Address and CEOs Presentation		24/11/09	1.6MB	Share
ACR	Appendix 3B		12/11/09	94.26KB	Share
ACR	Update on Ellavie regulatory process for Australian market		12/11/09	23.21KB	Share
ACR	Appendix 3B		09/11/09	166.9KB	Share
ACR	Appendix 3B		06/11/09	166.89KB	Share
ACR	Acrux appoints Credit Suisse as corporate advisor		06/11/09	20.89KB	Share
ACR	Appendix 3B		30/10/09	166.87KB	Share
ACR	Appendix 4C - Quarterly Cash Flow	PRICE SENSITIVE	30/10/09	89.25KB	Share
ACR	Acrux receives excellence award for achievement with AXIRON		29/10/09	39.54KB	Share
ACR	Appendix 3B		23/10/09	166.87KB	Share
ACR	Notice of Annual General Meeting		23/10/09	38.45KB	Share
ACR	2009 Annual Report		23/10/09	1.63MB	Share
ACR	Appendix 3B		15/10/09	166.87KB	Share
ACR	Appendix 3B		08/10/09	166.85KB	Share
ACR	Updated investor presentation, October 2009		06/10/09	1.16MB	Share
ACR	Acrux Announces Successful AXIRON Phase 3 Trial Results	PRICE SENSITIVE	29/09/09	86.73KB	Share
ACR	Acrux Signs Ellavie Distribution Agreement for Key European	PRICE SENSITIVE	24/09/09	89.94KB	Share
ACR	Acrux to proceed with AXIRON NDA following meeting with FDA	PRICE SENSITIVE	03/09/09	93.14KB	Share
ACR	Presentation at Bioshares Biotech Summit		01/09/09	722.08KB	Share
ACR	Appendix 4E and 30 June 2009 Financial Report	PRICE SENSITIVE	27/08/09	3.6MB	Share
ACR	Acrux Reports June 2009 Results		27/08/09	31.24KB	Share
ACR	Appendix 3B - Application for the quotation of additional se		17/08/09	166.86KB	Share
ACR	Appendix 4C - Quarterly Cash Flow	PRICE SENSITIVE	30/07/09	89.37KB	Share
ACR	Acrux News - July 2009		24/07/09	293.24KB	Share
ACR	Acrux completes Phase 3 trial of AXIRON		16/07/09	896.62KB	Share
ACR	Acrux signs Ellavie distribution agreement for South Korea	PRICE SENSITIVE	10/07/09	84.32KB	Share
ACR	Acrux signs Ellavie distribution agreement for Switzerland	PRICE SENSITIVE	19/06/09	27.04KB	Share
ACR	Arbitration Panel Rules in Favour of Acrux	PRICE SENSITIVE	19/06/09	43.39KB	Share
ACR	Acrux signs Ellavie Distribution Agreement for South Africa	PRICE SENSITIVE	04/06/09	82.61KB	Share
ACR	Response to an ASX Price Query	PRICE SENSITIVE	02/06/09	128.9KB	Share
ACR	Response to an ASX Price Query	PRICE SENSITIVE	12/05/09	128.91KB	Share
ACR	Appendix 3B		23/04/09	112.57KB	Share
ACR	Appendix 4C - Quarterly Cash Flow	PRICE SENSITIVE	23/04/09	89.34KB	Share
ACR	Acrux News - April 2009		22/04/09	501.35KB	Share
ACR	Investor Presentation - April 2009		21/04/09	2.81MB	Share
ACR	Acrux receives interim arbitration ruling	PRICE SENSITIVE	14/04/09	26.27KB	Share
ACR	Acrux completes enrolment in Phase 3 trial of AXIRON	PRICE SENSITIVE	09/03/09	371.2KB	Share
ACR	Appendix 3B		05/03/09	112.63KB	Share
ACR	Update on Evamist and KV Pharmaceutical	PRICE SENSITIVE	03/03/09	30.33KB	Share
ACR	Acrux Files Half Year Results		25/02/09	62.73KB	Share
ACR	Half Year Accounts and Appendix 4D	PRICE SENSITIVE	25/02/09	178.26KB	Share
ACR	Positive clinical trial results for contraceptive spray	PRICE SENSITIVE	20/02/09	51.33KB	Share
ACR	Appendix 4C quarterly cash flow report	PRICE SENSITIVE	30/01/09	32.63KB	Share
ACR	Acrux ceases investment in Fentanyl MDTS	PRICE SENSITIVE	30/01/09	19.59KB	Share
ACR	Ceasing to be a substantial holder		15/01/09	70.43KB	Share
ACR	Response to an ASX Price Query	PRICE SENSITIVE	12/01/09	107.75KB	Share
ACR	Acrux News - December 2008		16/12/08	458.16KB	Share
ACR	SUBMISSION TO FDA OF FIRST ANIMAL HEALTH PRODUCT	PRICE SENSITIVE	15/12/08	20.81KB	Share
ACR	Submits Marketing Application for Ellavie in Europe		08/12/08	20.43KB	Share
ACR	Appendix 3Y - Change of Director's Interest Notice		27/11/08	14.24KB	Share

ACR Appendix 3B
21/12/10		166.87KB	Share
ACR Change in substantial holding
17/12/10		79.92KB	Share
ACR Appendix 3B
17/12/10		166.89KB	Share
ACR Acrux receives US$87 million from Lilly
09/12/10		20.06KB	Share
ACR Appendix 3Y
06/12/10		31.05KB	Share
ACR Appendix 3B
06/12/10		166.89KB	Share
ACR Appendix 3B
03/12/10		167.5KB	Share
ACR 2010 AGM Resolution Results
30/11/10		56.15KB	Share
ACR 2010 AGM Presentations
30/11/10	PRICE SENSITIVE	2.09MB	Share
ACR Change in substantial holding
29/11/10		86.31KB	Share
ACR Appendix 3B
25/11/10		166.93KB	Share
ACR FDA Approval for AXIRON
24/11/10	PRICE SENSITIVE	82.21KB	Share
ACR Market Update
24/11/10	PRICE SENSITIVE	49.12KB	Share
ACR Trading Halt
24/11/10	PRICE SENSITIVE	41.63KB	Share
ACR Change in substantial holding
04/11/10		86.78KB	Share
ACR Response to ASX Price Query
01/11/10	PRICE SENSITIVE	95.12KB	Share
ACR Change in substantial holding
29/10/10		92.01KB	Share
ACR Appendix 4C - Quarterly Cash Flow Report
29/10/10	PRICE SENSITIVE	89.74KB	Share
ACR 2010 AGM Notice
22/10/10		242.48KB	Share
ACR 2010 Annual Report
21/10/10		1.02MB	Share
ACR Acrux wins two 2010 Governor of Victoria Export Awards
05/10/10		18.68KB	Share
ACR Appendix 3Y
31/08/10		31.18KB	Share
ACR Appendix 3B
31/08/10		186.46KB	Share
ACR Acrux Reports Maiden Profit of $46.6 Million
24/08/10		30.66KB	Share
ACR Appendix 4E and 30 June 2010 Financial Report
24/08/10	PRICE SENSITIVE	241.25KB	Share
ACR Update on Acrux female health products
10/08/10	PRICE SENSITIVE	26.48KB	Share
ACR Appendix 4C - Quarterly Cash Flow Report
30/07/10	PRICE SENSITIVE	90.21KB	Share
ACR Acrux CEO nominated in Entrepreneur Of The Year awards
17/06/10		83.08KB	Share
ACR Investor Presentation 20 May 2010
20/05/10		2.24MB	Share
ACR Settlement Agreement Transferring Luramist Assets to Acrux
11/05/10	PRICE SENSITIVE	20.59KB	Share
ACR Appendix 4C - Quarterly Cash Flow Report
30/04/10	PRICE SENSITIVE	89.51KB	Share
ACR New Drug Application for AXIRON accepted for review by FDA
15/04/10	PRICE SENSITIVE	19.95KB	Share
ACR Appendix 3Y - Change of director's interest notice
06/04/10		10.69KB	Share
ACR Acrux to regain rights to testosterone spray from Vivus
01/04/10	PRICE SENSITIVE	20.34KB	Share
ACR Appendix 3B
19/03/10		166.87KB	Share
ACR Appendix 3B
18/03/10		166.85KB	Share
ACR AXIRON Licensing Presentation
17/03/10		374.33KB	Share
ACR Acrux and Eli Lilly sign global licensing deal for AXIRON
16/03/10	PRICE SENSITIVE	31.23KB	Share
ACR Market Update - A New Era For Acrux
16/03/10	PRICE SENSITIVE	62.02KB	Share
ACR Trading Halt
15/03/10	PRICE SENSITIVE	41.78KB	Share
ACR Appendix 3B
11/03/10		166.87KB	Share
TSN +ACR ADU AED AEJ AEZ AIO AJA RCM AMU ATM AVG AVX AXM AZZ ASQ BCS BLY BUL CAA CAH CBH CCP CDI PRG CIX CMV COK COZ CPL CRE CSV CTO CUV CVC CWT CXC CXM DCG DKN DLS DML DOM EAU EPX FEA FGE FML FPG FRS GDO ETM GPM GWR GXY GZL HDI NGI HGO HIG HIN HTA IDT ILF IMD IOH ITO IVA KAM KMD KRL KRM LLA MAE AEV MCE MCP MDT MEL MFG MIN 5GN GG8 MMW MRE MSF MTU MYR MYS NAN NBS NEC DTZ NGE NGF NKP NOD KZA NVT OAK OEL SYN AKE PBP ATH PME PPI PRU PTN AX1 RCI RCT VAU REF RFE RRL RXM SAR SFC SFH SFR SGN SGT SLR SNO SPL SRV SSM SUL TAM TCQ TGA TOX TPM TZL UBI UNS VIR VMG VPE VRL VTA WDS WEC WTP WYL ZSPSandP Announces March SP/ASX Index Rebalance
05/03/10		35.82KB	Share
ACR Appendix 3B
25/02/10		166.88KB	Share
ACR Acrux Files Half Year Results
24/02/10		39.93KB	Share
ACR Half Year Accounts and Appendix 4D
24/02/10	PRICE SENSITIVE	281.88KB	Share
ACR Appendix 4C - Quarterly Cash Flow
29/01/10	PRICE SENSITIVE	89.3KB	Share
ACR Acrux Submits New Drug Application for AXIRON to FDA
27/01/10	PRICE SENSITIVE	768.01KB	Share
ACR Appendix 3B
07/12/09		166.91KB	Share
ACR Appendix 3B
27/11/09		166.93KB	Share
ACR 2009 AGM Resolutions Results
24/11/09		54.33KB	Share
ACR 2009 AGM Chairmans Address and CEOs Presentation
24/11/09		1.6MB	Share
ACR Appendix 3B
12/11/09		94.26KB	Share
ACR Update on Ellavie regulatory process for Australian market
12/11/09		23.21KB	Share
ACR Appendix 3B
09/11/09		166.9KB	Share
ACR Appendix 3B
06/11/09		166.89KB	Share
ACR Acrux appoints Credit Suisse as corporate advisor
06/11/09		20.89KB	Share
ACR Appendix 3B
30/10/09		166.87KB	Share
ACR Appendix 4C - Quarterly Cash Flow
30/10/09	PRICE SENSITIVE	89.25KB	Share
ACR Acrux receives excellence award for achievement with AXIRON
29/10/09		39.54KB	Share
ACR Appendix 3B
23/10/09		166.87KB	Share
ACR Notice of Annual General Meeting
23/10/09		38.45KB	Share
ACR 2009 Annual Report
23/10/09		1.63MB	Share
ACR Appendix 3B
15/10/09		166.87KB	Share
ACR Appendix 3B
08/10/09		166.85KB	Share
ACR Updated investor presentation, October 2009
06/10/09		1.16MB	Share
ACR Acrux Announces Successful AXIRON Phase 3 Trial Results
29/09/09	PRICE SENSITIVE	86.73KB	Share
ACR Acrux Signs Ellavie Distribution Agreement for Key European
24/09/09	PRICE SENSITIVE	89.94KB	Share
ACR Acrux to proceed with AXIRON NDA following meeting with FDA
03/09/09	PRICE SENSITIVE	93.14KB	Share
ACR Presentation at Bioshares Biotech Summit
01/09/09		722.08KB	Share
ACR Appendix 4E and 30 June 2009 Financial Report
27/08/09	PRICE SENSITIVE	3.6MB	Share
ACR Acrux Reports June 2009 Results
27/08/09		31.24KB	Share
ACR Appendix 3B - Application for the quotation of additional se
17/08/09		166.86KB	Share
ACR Appendix 4C - Quarterly Cash Flow
30/07/09	PRICE SENSITIVE	89.37KB	Share
ACR Acrux News - July 2009
24/07/09		293.24KB	Share
ACR Acrux completes Phase 3 trial of AXIRON
16/07/09		896.62KB	Share
ACR Acrux signs Ellavie distribution agreement for South Korea
10/07/09	PRICE SENSITIVE	84.32KB	Share
ACR Acrux signs Ellavie distribution agreement for Switzerland
19/06/09	PRICE SENSITIVE	27.04KB	Share
ACR Arbitration Panel Rules in Favour of Acrux
19/06/09	PRICE SENSITIVE	43.39KB	Share
ACR Acrux signs Ellavie Distribution Agreement for South Africa
04/06/09	PRICE SENSITIVE	82.61KB	Share
ACR Response to an ASX Price Query
02/06/09	PRICE SENSITIVE	128.9KB	Share
ACR Response to an ASX Price Query
12/05/09	PRICE SENSITIVE	128.91KB	Share
ACR Appendix 3B
23/04/09		112.57KB	Share
ACR Appendix 4C - Quarterly Cash Flow
23/04/09	PRICE SENSITIVE	89.34KB	Share
ACR Acrux News - April 2009
22/04/09		501.35KB	Share
ACR Investor Presentation - April 2009
21/04/09		2.81MB	Share
ACR Acrux receives interim arbitration ruling
14/04/09	PRICE SENSITIVE	26.27KB	Share
ACR Acrux completes enrolment in Phase 3 trial of AXIRON
09/03/09	PRICE SENSITIVE	371.2KB	Share
ACR Appendix 3B
05/03/09		112.63KB	Share
ACR Update on Evamist and KV Pharmaceutical
03/03/09	PRICE SENSITIVE	30.33KB	Share
ACR Acrux Files Half Year Results
25/02/09		62.73KB	Share
ACR Half Year Accounts and Appendix 4D
25/02/09	PRICE SENSITIVE	178.26KB	Share
ACR Positive clinical trial results for contraceptive spray
20/02/09	PRICE SENSITIVE	51.33KB	Share
ACR Appendix 4C quarterly cash flow report
30/01/09	PRICE SENSITIVE	32.63KB	Share
ACR Acrux ceases investment in Fentanyl MDTS
30/01/09	PRICE SENSITIVE	19.59KB	Share
ACR Ceasing to be a substantial holder
15/01/09		70.43KB	Share
ACR Response to an ASX Price Query
12/01/09	PRICE SENSITIVE	107.75KB	Share
ACR Acrux News - December 2008
16/12/08		458.16KB	Share
ACR SUBMISSION TO FDA OF FIRST ANIMAL HEALTH PRODUCT
15/12/08	PRICE SENSITIVE	20.81KB	Share
ACR Submits Marketing Application for Ellavie in Europe
08/12/08		20.43KB	Share
ACR Appendix 3Y - Change of Director's Interest Notice
27/11/08		14.24KB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.8¢		Change 0.000(0.00%)		Mkt cap ! $7.366M

Open	High	Low	Value	Volume
1.8¢	1.8¢	1.8¢	$5.04K	280K

Buyers (Bids)

No.	Vol.	Price($)
6	916823	1.7¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	265520	1

View Market Depth

No.	Vol.	Price($)
6	916823	0.017
11	1275173	0.016
5	1311882	0.015
2	140000	0.014
3	486850	0.013

Price($)	Vol.	No.
0.019	265520	1
0.020	56617	4
0.021	111922	1
0.022	100000	1
0.023	381179	1

Last trade - 14.14pm 29/07/2025 (20 minute delay)


Last 1.8¢		Change 0.000 ( 5.26 %)
Open	High	Low	Volume
1.8¢	1.8¢	1.8¢	53130
Last updated 11.05am 29/07/2025 ?

ACR (ASX) Chart

ACRUX LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available